Tamoxifen-induced [Ca2+]i rises and Ca2+-independent cell death in human oral cancer cells

Journal of Receptors and Signal Transduction

Volumn 27, Issue 5-6, 2007, Pages 353-367

  Chu, Sau Tung ^a   Huang, Chorng Chih ^b   Huang, Chun Jen ^c,d   Cheng, Jin Shiung ^e   Chai, Kuo Liang ^e   Cheng, He Hsiung ^f   Fang, Yi Chien ^g,h   Chi, Chao Chuan ^a   Su, Hsing Hao ^a   Chou, Chiang Ting ^a   Jan, Chung Ren ^a  

^a KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

^b TZU HUI INSTITUTE OF TECHNOLOGY   (Taiwan)

^c KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^d KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^e Yongkang Veterans Hospital   (Taiwan)

^f CHI MEI MEDICAL CENTER   (Taiwan)

^g ZUOYING ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^h NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

Ca2+; Fura 2; Oral cancer cells; Tamoxifen; Thapsigargin

Indexed keywords

1 [[6 (3 METHOXYESTRA 1,3,5(10) TRIEN 17BETA YL)AMINO]HEXYL] 1H PYRROLE 2,5 DIONE; CALCIUM CHANNEL L TYPE; CALCIUM ION; FLUORESCENT DYE; FULVESTRANT; FURA 2; PHOSPHOLIPASE C; PROTEIN KINASE C; TAMOXIFEN; THAPSIGARGIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CALCIUM CELL LEVEL; CALCIUM SIGNALING; CALCIUM TRANSPORT; CANCER CELL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOSOL; CYTOTOXICITY; ENDOPLASMIC RETICULUM; ENZYME INHIBITION; FLUORESCENCE ANALYSIS; HUMAN; HUMAN CELL; MOUTH CANCER;

CALCIUM; CALCIUM CHANNEL BLOCKERS; CALCIUM SIGNALING; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CYTOSOL; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTROGEN RECEPTOR MODULATORS; HUMANS; MOUTH NEOPLASMS; PROTEIN KINASE C; TAMOXIFEN; THAPSIGARGIN;

EID: 37548999386     PISSN: 10799893     EISSN: 15324281     Source Type: Journal    
DOI: 10.1080/10799890701699660     Document Type: Article

References (37)

1. Daly MB. Tamoxifen in ductal carcinoma in situ. Semin Oncol 2006, 33, 647-649.
2. Bao T, Prowell T, Stearns V. Chemoprevention of breast cancer: tamoxifen, raloxifene, and beyond. Am J Ther 2006, 13, 337-348.
3. Grilli S. Tamoxifen (TAM): The dispute goes on. Ann Ist Super Sanita 2006, 42, 170-173.
4. Brown RJ, Davidson NE. Adjuvant hormonal therapy for premenopausal women with breast cancer. Semin Oncol 2006, 33, 657-663.
5. Shibutani S. Tamoxifen is a genotoxic carcinogen. Chem Res Toxicol 2005, 18, 1509-1511.
6. Coiret G, Borowiec AS, Mariot P, Ouadid-Ahidouch H, Matifat F. The antiestrogen tamoxifen activates BK channels and stimulates proliferation of MCF-7 breast cancer cells. Mol Pharmacol 2007, 71, 841-845.
7. Kim KJ, Lee CJ, Lee U, Yoo YM. Tamoxifen-induced cell death and expression of neurotrophic factors in cultured C6 glioma cells. J Neurooncol 2005, 71, 121-125.
8. Petinari L, Kohn LK, de Carvalho JE, Genari SC. Cytotoxicity of tamoxifen in normal and tumoral cell lines and its ability to induce cellular transformation in vitro. Cell Biol Int 2004, 28, 531-539.
9. Salami S, Karami-Tehrani F. Biochemical studies of apoptosis induced by tamoxifen in estrogen receptor positive and negative breast cancer cell lines. Clin Biochem 2003, 36, 247-253.
10. Kanter-Lewensohn L, Girnita L, Girnita A, Dricu A, Olsson G, Leech L, Nilsson G, Hilding A, Wejde J, Brismar K, Larsson O. Tamoxifen-induced cell death in malignant melanoma cells: Possible involvement of the insulin-like growth factor-1 (IGF-1) pathway. Mol Cell Endocrinol 2000, 165, 131-137.
11. El Etreby MF, Liang Y, Lewis RW. Induction of apoptosis by mifepristone and tamoxifen in human LNCaP prostate cancer cells in culture. Prostate 2000, 43, 31-42.
12. Berridge MJ. Inositol trisphosphate and calcium signaling. Nature 1993, 361, 315-325.
13. Berridge MJ. Elementary and global aspects of calcium signaling. J Physiol 1997, 499, 291-306.
14. Bootman MD, Berridge MJ, Roderick HL. Calcium signalling: More messengers, more channels, more complexity. Curr Biol 2002, 12, R563-R565.
15. Annunziato L, Amoroso S, Pannaccione A, Cataldi M, Pignataro G, D'Alessio A, Sirabella R, Secondo A, Sibaud L, Di Renzo GF. Apoptosis induced in neuronal cells by oxidative stress: role played by caspases and intracellular calcium ions. Toxicol Lett 2003, 139, 125-133.
16. 2+ movement in human osteosarcoma cells. Pharmacol Toxicol 2002, 91, 34-39.
17. 2+ levels in human breast cancer cells. Breast Cancer Res Treat 2002, 71, 125-131.
18. 2+ mobilization in bladder female transitional carcinoma cells. Arch Toxicol 2001, 75, 184-188.
19. Wong DY, Chang KW, Chen CF, Chang RC. Characterization of two new cell lines derived from oral cavity human squamous cell carcinomas - OC1 and OC2. J Oral Maxillofac Surg 1990, 48, 385-390.
20. Liao PH, Chen SL, Shih HC, Chou MY. Induction of apoptosis in human oral cancer cell lines, OC2 and TSCCa, by chingwaysan. Am J Chin Med 2005, 33, 21-27.
21. Huang TH, Ding SJ, Hsu TZ, Lee ZD, Kao CT. Root canal sealers induce cytotoxicity and necrosis. J Mater Sci Mater Med 2004, 15, 767-771.
22. i increases and cell proliferation induced by the carcinogen safrole in human oral cancer cells. Naunyn Schmiedebergs Arch Pharmacol 2005, 372, 88-94.
23. Ho CC, Yang XW, Lee TL, Liao PH, Yang SH, Tsai CH, Chou MY. Activation of p53 signalling in acetylsalicylic acid-induced apoptosis in OC2 human oral cancer cells. Eur J Clin Invest 2003, 33, 875-882.
24. Huang TH, Tsai CY, Chen SL, Kao CT. An evaluation of the cytotoxic effects of orthodontic bonding adhesives upon a primary human oral gingival fibroblast culture and a permanent, human oral cancer-cell line. J Biomed Mater Res 2002, 63, 814-821.
25. 2+ indicators with greatly improved fluorescence properties. J Biol Chem 1985, 260, 3440-3450.
26. Merritt JE, Jacob R, Hallam TJ. Use of manganese to discriminate between calcium influx and mobilization from internal stores in stimulated human neutrophils. J Biol Chem 1989, 264, 1522-1527.
27. 2+-ATPase. Proc Natl Acad Sci USA 1990, 87, 2466-2470.
28. Thompson AK, Mostafapour SP, Denlinger LC, Bleasdale JE, Fisher SK. The aminosteroid U-73122 inhibits muscarinic receptor sequestration and phosphoinositide hydrolysis in SK-N-SH neuroblastoma cells. A role for Gp in receptor compartmentation. J Biol Chem 1991, 266, 23856-23862.
29. Florenzano F, Viscomi MT, Cavaliere F, Volonte C, Molinari M. The role of ionotropic purinergic receptors (P2X) in mediating plasticity responses in the central nervous system. Adv Exp Med Biol 2006, 557, 77-100.
30. Tsien RY. New calcium indicators and buffers with high selectivity against magnesium and protons: design, synthesis, and properties of prototype structures. Biochemistry 1980, 19, 2396-404.
31. Jan CR, An-Jen C, Chang HT, Roan CJ, Lu YC, Jiann BP, Ho CM, Huang JK. The anti-breast cancer drug tamoxifen alters Ca2+ movement in Chinese hamster ovary (CHO-K1) cells. Arch Toxicol 2003, 77, 160-166.
32. Quinn T, Molloy M, Smyth A, Baird AW. Capacitative calcium entry in guinea pig gallbladder smooth muscle in vitro. Life Sci 2004, 74, 1659-1669.
33. Harper JL, Camerini-Otero CS, Li AH, Kim SA, Jacobson KA, Daly JW. Dihydropyridines as inhibitors of capacitative calcium entry in leukemic HL-60 cells. Biochem. Pharmacol 2003, 65, 329-338.
34. Young RC, Schumann R, Zhang P. Nifedipine block of capacitative calcium entry in cultured human uterine smooth-muscle cells. J Soc Gynecol Investig 2001, 8, 210-215.
35. McCarty MF. PKC-mediated modulation of L-type calcium channelsmay contribute to fat-induced insulin resistance. Med Hypotheses 2006, 66, 824-831.
36. Venkatachalam K, Zheng F, Gill DL. Control of TRPC and store-operated channels by protein kinase C. Novartis Found Symp 2004, 258, 172-185.
37. Ramachandran C, Khatib Z, Petkarou A, Fort J, Fonseca HB, Melnick SJ, Escalon E. Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. J Neurooncol 2004, 67, 19-28.